Lightning-Link^® Conjugation Kits: Consistent Performance On A Broad Scale

This content is brought to you by Abcam, a Danaher Operating Company.

This study addresses the critical challenges researchers encounter in selecting conjugated primary antibodies. Traditional conjugation methods are being recognized as inefficient, requiring a higher level of expertise and complex protocols, taking up valuable time and resources. Lightning-Link^® labeling technology offers a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results. This study utilizes four Lightning-Link conjugation kits and substantiates their ability to produce batch-to-batch consistency while scaling to meet your experiment's needs.